Upfront Enzyme Replacement via Erythrocyte Transfusions for PNP Deficiency

Arpaia E, Benveniste P, di Cristofano A, Gu Y, Dalal I, Kelly S, et al. Mitochondrial basis for immune deficiency. Evidence from purine nucleoside phosphorylase-deficient mice. J Exp Med. 2000;191:2197–208. https://doi.org/10.1084/jem.191.12.2197. Iwahana H, Itakura M. Inherited disorders of uric acid metabolism--classification, enzymatic- and DNA-diagnosis. Nihon Rinsho. 1996;54:3303–8. Rich KC, Majias E, Fox IH. Purine nucleoside phosphorylase deficiency: improved metabolic and immunologic function with erythrocyte transfusions. N Engl J Med. 1980;303:973–7. https://doi.org/10.1056/NEJM198010233031705. Staal GE, Stoop JW, Zegers BJ, Siegenbeek van Heukelom LH, van der Vlist MJ, Wadman SK, et al. Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes. J Clin Invest. 1980;65:103–8. https://doi.org/10.1172/JCI109639. la Marca G, Canessa C, Giocaliere E, Romano F, Malvagia S, Funghini S, et al. Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots. J Allergy Clin Immunol. 2014;134:155–9. https://doi.org/10.1016/j.jaci.2014.01.040. Kleijer WJ, Hussaarts-Odijk LM, Los FJ, Pijpers L, de Bree PK, Duran M. Prenatal diagnosis of purine nucleoside phosphorylase deficiency in the first and second trimesters of pregnancy. Prenat Diagn. 1989;9:401–7. https://doi.org/10.1002/pd.1970090605. Singh V. Cross correction following haemopoietic stem cell transplant for purine nucleoside phosphorylase deficiency: engrafted donor-derived white blood cells provide enzyme to residual enzyme-deficient recipient cells. JIMD Rep. 2012;6:39–42. https://doi.org/10.1007/8904_2012_126. Myers LA, Hershfield MS, Neale WT, Escolar M, Kurtzberg J. Purine nucleoside phosphorylase deficiency (PNP-def) presenting with lymphopenia and developmental delay: successful correction with umbilical cord blood transplantation. J Pediatr. 2004;145:710–2. https://doi.org/10.1016/j.jpeds.2004.06.075. Schejter YD, Even-Or E, Shadur B, NaserEddin A, Stepensky P, Zaidman I. The broad clinical spectrum and transplant results of PNP deficiency. J Clin Immunol. 2020;40:123–30. https://doi.org/10.1007/s10875-019-00698-1. Mansouri A, Min W, Cole CJ, Josselyn SA, Henderson JT, van Eede M, et al. Cerebellar abnormalities in purine nucleoside phosphorylase deficient mice. Neurobiol Dis. 2012;47:201–9. https://doi.org/10.1016/j.nbd.2012.04.001. Boskabadi HMM. Evaluation of the severity and duration of thrombocytopenia following exchange transfusion in neonatal hyperbilirubinemia. Iran J Ped Hematol Oncol. 2019;9:91–7. https://doi.org/10.18502/ijpho.v9i2.608. Chcacham SKJ, Dutta S, Kumar P. Adverse events following blood exchange transfusion for neonatal hyperbilirubinemia: a prospective study. Journal of Clinical Neonatology. 2019;8:79–84. Fitzhugh CD, Cordes S, Taylor T, Coles W, Roskom K, Link M, et al. At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT. Blood. 2017;130:1946–8. https://doi.org/10.1182/blood-2017-03-772392.